Homeostasis of telomere length rather than telomere shortening after allogeneic peripheral blood stem cell transplantation

Blood

Volumn 101, Issue 1, 2003, Pages 358-362

  Roelofs, Helene ^a   De Pauw, Elmar S D ^a   Zwinderman, Aeilko H ^a   Opdam, Sonja M ^a   Willemze, Roel ^a   Tanke, Hans J ^a   Fibbe, Willem E ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL COUNT; CELL DIVISION; CELL LINEAGE; CLINICAL ARTICLE; CONTROLLED STUDY; GRANULOCYTE; HEMATOPOIETIC CELL; HOMEOSTASIS; HUMAN; HUMAN CELL; MONOCYTE; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; T LYMPHOCYTE SUBPOPULATION; TELOMERE;

EID: 0037221969     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-06-1832     Document Type: Article

References (37)

1. Zakian VA. Telomeres: Beginning to understand the end. Science. 1995;270:1601-1607.
2. Griffith JD, Comeau L, Rosenfield S, et al. Mammalian telomeres end in a large duplex loop. Cell.1999;97:503-514.
3. Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM. Evidence for a mitotic clock in human hematopoietic stem cells: Loss of telomeric DNA with age. Proc Natl Acad Sci U S A. 1994;91:9857-9860.
4. Allsopp RC, Vaziri H, Patterson C, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci U S A. 1992;89:10114-10118.
5. Akiyama M, Hoshi Y, Sakurai S, Yamada H, Yamada O, Mizoguchi H. Changes of telomere length in children after hematopoietic stem cell transplantation. Bone Marrow Transplant. 1998;21:167-171.
6. Akiyama M, Asai O, Kuraishi Y, et al. Shortening of telomeres in recipients of both autologous and allogeneic hematopoietic stem cell transplantation, Bone Marrow Transplant. 2000;25:441-447.
7. Lee J, Kook H, Chung I, et al. Telomere length changes in patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant. 1999;24:411-415.
8. Notaro R, Cimmino A, Tabarini D, Rotoli B, Luzzatto L. In vivo telomere dynamics of human hematopoietic stem cells. Proc Natl Acad Sci U S A. 1997;94:13782-13785.
9. Wynn RF, Cross MA, Hatton C, et al. Accelerated telomere shortening in young recipients of allogeneic bone marrow transplants. Lancet. 1998;351:178-181.
10. Wynn R, Thornley I, Freedman M, Saunders EF. Telomere shortening in leucocyte subsets of longterm survivors of allogeneic bone marrow transplantation. Br J Haematol. 1999;105:997-1001.
11. Mathioudakis G, Storb R, McSweeney PA, et al. Polyclonal hematopoiesis with variable telomere shortening in human long-term allogeneic marrow graft recipients. Blood. 2000;96:3991-3994.
12. de Pauw ES, Otto SA, Wijnen JT, et al. Long-term follow-up of recipients of allogeneic bone marrow grafts reveals no progressive telomere shortening and provides no evidence for haematopoietic stem cell exhaustion. Br J Haematol. 2002;116:491-496.
13. Rufer N, Brummendorf TH, Chapuis B, Helg C, Lansdorp PM, Roosnek E. Accelerated telomere shortening in hematological lineages is limited to the first year following stem cell transplantation. Blood. 2001;97:575-577.
14. Thornley I, Sutherland R, Wynn R, et al. Early hematopoietic reconstitution after clinical stem cell transplantation: Evidence for stochastic stem cell behavior and limited acceleration in telomere loss. Blood. 2002;99:2387-2396.
15. Robertson JD, Testa NG, Russell NH, et al. Accelerated telomere shortening following allogeneic transplantation is independent of the cell source and occurs within the first year post transplant. Bone Marrow Transplant. 2001;27:1283-1286.
16. Shay JW. Accelerated telomere shortening in bone-marrow recipients. Lancet. 1998;351:153-154.
17. Schmitz N, Dreger P, Suttorp M, et al. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood. 1995;85:1666-1672.
18. Barge RM, Brouwer RE, Beersma MF, et al. Comparison of allogeneic T cell-depleted peripheral blood stem cell and bone marrow transplantation: Effect of stem cell source. Bone Marrow Transplant. 2001;27:1053-1058.
19. Korbling M, Przepiorka D, Huh YO, et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: Potential advantage of blood over marrow allografts. Blood. 1995;85:1659-1665.
20. Bensinger WI, Clift R, Martin P, et al. Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: A retrospective comparison with marrow transplantation. Blood. 1996;88:2794-2800.
21. Schmitz N, Bacigalupo A, Labopin M, et al. Transplantation of peripheral blood progenitor cells from HLA-identical sibling donors: European Group for Blood and Marrow Transplantation (EBMT). Br J Haematol. 1996;95:715-723.
22. Mahmoud H, Fahmy O, Kamel A, Kamel M, El Haddad A, El Kadi D. Peripheral blood vs bone marrow as a source for allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 1999;24:355-358.
23. Champlin RE, Schmitz N, Horowitz MM, et al. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation: IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT). Blood. 2000;95:3702-3709.
24. + cell dose predicts survival posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies. Blood. 1996;88:3223-3229.
25. Vellenga E, Sizoo W, Hagenbeek A, Lowenberg B. Different repopulation kinetics of erythroid (BFU-E), myeloid (CFU-GM) and T lymphocyte (TL-CFU) progenitor cells after autologous and allogeneic bone marrow transplantation. Br J Haematol. 1987;65:137-142.
26. Messner HA, Curtis JE, Minden MD, et al. Clonogenic hemopoietic precursors in bone marrow transplantation. Blood. 1987;70:1425-1432.
27. Domenech J, Linassier C, Gihana E, et al. Prolonged impairment of hematopoiesis after highdose therapy followed by autologous bone marrow transplantation. Blood. 1995;85:3320-3327.
28. Weng NP, Palmer LD, Levine BL, Lane HC, June CH, Hodes RJ. Tales of tails: Regulation of telomere length and telomerase activity during lymphocyte development, differentiation, activation, and aging. Immunol Rev. 1997;160:43-54.
29. Hiyama K, Hirai Y, Kyoizumi S, et al. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol. 1995;155:3711-3715.
30. Counter CM, Gupta J, Harley CB, Leber B, Bacchetti S. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood. 1995;85:2315-2320.
31. Broccoli D, Young JW, de Lange T. Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci U S A. 1995;92:9082-9086.
32. Chiu CP, Dragowska W, Kim NW, et al. Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow. Stem Cells. 1996;14:239-248.
33. Bodnar AG, Kim NW, Effros RB, Chiu CP. Mechanism of telomerase induction during T cell activation. Exp Cell Res. 1996;228:58-64.
34. Pan C, Xue BH, Ellis TM, Peace DJ, Diaz MO. Changes in telomerase activity and telomere length during human T lymphocyte senescence. Exp Cell Res. 1997;231:346-353.
35. Mackall CL, Fleisher TA, Brown MR, et al. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med. 1995;332:143-149.
36. Godthelp BC, Van Eggermond MC, van Tol MJ, Vossen JM, van den Elsen PJ. T cell immune reconstitution after allogeneic bone marrow transplantation in bare lymphocyte syndrome. Hum Immunol. 2000;61:898-907.
37. Weng NP, Levine BL, June CH, Hodes RJ. Human naive and memory T lymphocytes differ in telomeric length and replicative potential. Proc Natl Acad Sci U S A. 1995;92:11091-11094.